Higher rates of diabetic ketoacidosis and admission to the paediatric intensive care unit among newly diagnosed children with type 1 diabetes in Kuwait during the COVID-19 pandemic

Dalia Al-Abdulrazzaq 1, Abdullah Alkandari 2, Fatemah Alhusaini 3, Naser Alenazi 4, Unjali P Gujral 5, K M Venkat Narayan 6, Hessa Al-Kandari 2 7; CODeR group

Affiliations

01 March 2022

-

doi: 10.1002/dmrr.3506

Abstract

Introduction: The COVID-19 pandemic might have a multifaceted effect on children with type 1 diabetes (T1D), either directly through infection itself or indirectly due to measures implemented by health authorities to control the pandemic.

Objective: To compare data on children newly diagnosed with T1D in Kuwait during the COVID-19 pandemic to the pre-pandemic period.

Research design and methods: We analysed data on children aged 12 years or less registered in the Childhood-Onset Diabetes electronic Registry (CODeR) in Kuwait. Data were incidence rate (IR), diabetic ketoacidosis (DKA), and its severity and admission to the paediatric intensive care unit (PICU).

Results: The IR of T1D was 40.2 per 100,000 (95% CI; 36.0-44.8) during the COVID-19 pandemic period and was not statistically different from pre-pandemic. A higher proportion of incident T1D cases presented with DKA and were admitted to the PICU during the pandemic (52.2% vs. 37.8%: p ˂ 0.001, 19.8% vs. 10.9%; p = 0.002, respectively). The COVID-19 pandemic was positively associated with presentation of DKA and admission to PICU (AOR = 1.73; 95% CI, 1.13-2.65; p = 0.012, AOR = 2.04; 95% CI, 1.13-3.67; p = 0.018, respectively). Children of families with a positive history for diabetes were less likely to present with DKA and get admitted to the PICU during the COVID-19 pandemic (AOR = 0.38; 95% CI, 0.20-0.74; p = 0.004, AOR = 0.22; 95% CI, 0.08-0.61; p = 0.004, respectively).

Conclusion: High rates of DKA at presentation and admission to PICU in incident T1D cases during the COVID-19 pandemic warrant further studies and effective mitigation efforts through increasing awareness, early detection, and timely intervention.

Keywords: COVID-19; Kuwait; children; diabetic ketoacidosis; type 1 diabetes.

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

FIGURE 1 Incidence of type 1 diabetes in children aged 12 years or younger by 3‐month interval (quarter) during the COVID‐19 pandemic period (2019–2020) in comparison to the pre‐pandemic period (2020–2021)

FIGURE 1 Incidence of type 1 diabetes in children aged 12 years or younger by 3‐month interval (quarter) during the COVID‐19 pandemic period (2019–2020) in comparison to the pre‐pandemic period (2020–2021)

Similar articles

Covid-19 infection in children and adolescents and its association with type 1 diabetes mellitus (T1d) presentation and management.

Karavanaki K, Rodolaki K, Soldatou A, Karanasios S, Kakleas K.Endocrine. 2023 May;80(2):237-252. doi: 10.1007/s12020-022-03266-7. Epub 2022 Dec 3.PMID: 36462147 Free PMC article. Review.

New-onset type 1 diabetes in Finnish children during the COVID-19 pandemic.

Salmi H, Heinonen S, Hästbacka J, Lääperi M, Rautiainen P, Miettinen PJ, Vapalahti O, Hepojoki J, Knip M.Arch Dis Child. 2022 Feb;107(2):180-185. doi: 10.1136/archdischild-2020-321220. Epub 2021 May 27.PMID: 34045208 Free PMC article.

Alarming increase in ketoacidosis in children and adolescents with newly diagnosed type 1 diabetes during the first wave of the COVID-19 pandemic in Israel.

Goldman S, Pinhas-Hamiel O, Weinberg A, Auerbach A, German A, Haim A, Zung A, Brener A, Strich D, Azoulay E, Levy-Khademi F, Ludar H, Koren I, Rachmiel M, Yackobovitch-Gavan M, Zuckerman-Levin N, David O, Halloun R, Cahn R, Ben-Ari T, Yeshayahu Y, Landau Z, Phillip M, Lebenthal Y.Pediatr Diabetes. 2022 Feb;23(1):10-18. doi: 10.1111/pedi.13296. Epub 2021 Dec 14.PMID: 34865288

Epidemiologic Characteristics of Children with Diabetic Ketoacidosis Treated in a Pediatric Intensive Care Unit in a 10-Year-Period: Single Centre Experience in Croatia.

Lah Tomulić K, Matko L, Verbić A, Milardović A, Severinski S, Kolić I, Baraba Dekanić K, Šerifi S, Butorac Ahel I.Medicina (Kaunas). 2022 May 5;58(5):638. doi: 10.3390/medicina58050638.PMID: 35630055 Free PMC article.

The global impact of COVID-19 pandemic on the incidence of pediatric new-onset type 1 diabetes and ketoacidosis: A systematic review and meta-analysis.

Rahmati M, Keshvari M, Mirnasuri S, Yon DK, Lee SW, Il Shin J, Smith L.J Med Virol. 2022 Nov;94(11):5112-5127. doi: 10.1002/jmv.27996. Epub 2022 Jul 22.PMID: 35831242 Free PMC article. Review.

Cited by

Incidence of Diabetes in Children and Adolescents During the COVID-19 Pandemic: A Systematic Review and Meta-Analysis.

D'Souza D, Empringham J, Pechlivanoglou P, Uleryk EM, Cohen E, Shulman R.JAMA Netw Open. 2023 Jun 1;6(6):e2321281. doi: 10.1001/jamanetworkopen.2023.21281.PMID: 37389869 Free PMC article.

Increased Rates of Hospitalized Children with Type 1 and Type 2 Diabetes Mellitus in Central Brooklyn during the COVID-19 Pandemic.

Miller A, Joseph S, Badran A, Umpaichitra V, Bargman R, Chin VL.Int J Pediatr. 2023 Apr 17;2023:4580809. doi: 10.1155/2023/4580809. eCollection 2023.PMID: 37101938 Free PMC article.

Insights in diabetes: Molecular mechanisms-Protectin DX, an anti-inflammatory and a stimulator of inflammation resolution metabolite of docosahexaenoic acid, protects against the development of streptozotocin-induced type 1 and type 2 diabetes mellitus in male Swiss albino mice.

Rengachar P, Polavarapu S, Das UN.Front Endocrinol (Lausanne). 2023 Jan 25;13:1053879. doi: 10.3389/fendo.2022.1053879. eCollection 2022.PMID: 36778598 Free PMC article.

Health-related quality of life of children and adolescents with type 1 diabetes during the COVID-19 pandemic in Kuwait.

Al-Abdulrazzaq D, Khalifa D, Alqaisi T, Al-Juailla F, Othman F, Qabazard S, Al-Kandari H.Front Public Health. 2022 Dec 23;10:1056967. doi: 10.3389/fpubh.2022.1056967. eCollection 2022.PMID: 36620301 Free PMC article.

Covid-19 infection in children and adolescents and its association with type 1 diabetes mellitus (T1d) presentation and management.

Karavanaki K, Rodolaki K, Soldatou A, Karanasios S, Kakleas K.Endocrine. 2023 May;80(2):237-252. doi: 10.1007/s12020-022-03266-7. Epub 2022 Dec 3.PMID: 36462147 Free PMC article. Review.

KMEL References

https://pubmed.ncbi.nlm.nih.gov/

References

  1.  
    1. Seow CJ, Koh AWC, Lian JX, Dalan R, Boehm BO. Non autoimmune type 1B diabetes after mild COVID‐19: report of three cases. Diabetes Metab Res Rev. 2021;37(5):e3438. - PMC - PubMed
  2.  
    1. Maddaloni E, Buzzetti R. Covid‐19 and diabetes mellitus: unveiling the interaction of two pandemics. Diabetes Metab Res Rev. 2020;36(7):e33213321. - PMC - PubMed
  3.  
    1. Sharif K, Watad A, Coplan L, Amital H, Shoenfeld Y, Afek A. Psychological stress and type 1 diabetes mellitus: what is the link? Expert Rev Clin Immunol. 2018;14(12):1081‐1088. - PubMed
  4.  
    1. Caruso I, Molfetta SD, Guarini F, et al. Reduction of hypoglycaemia, lifestyle modifications and psychological distress during lockdown following SARS‐CoV‐2 outbreak in type 1 diabetes. Diabetes Metab Res Rev. 2021;37(6):e3404. - PubMed
  5.  
    1. Maddaloni E, Coraggio L, Pieralice S, Carlone A, Pozzilli P, Buzzetti R. Effects of COVID‐19 lockdown on glucose control: continuous glucose monitoring data from people with diabetes on intensive insulin therapy. Diabetes Care. 2020;43(8):e86‐e87. - PubMed
  6.  
    1. Silverii GA, Poggi CD, Dicembrini I, Monami M, Mannucci E. Glucose control in diabetes during home confinement for the first pandemic wave of COVID‐19: a meta‐analysis of observational studies. Acta Diabetol. Published online August 20, 2021. doi:10.1007/s00592-021-01754-2 - PMC - PubMed
  7.  
    1. Ludwig L, Scheyer N, Remen T, Guerci B. The impact of COVID‐19 lockdown on metabolic control and access to healthcare in people with diabetes: the CONFI‐DIAB cross‐sectional study. Diabetes Ther 2021;12(8):2207‐2221. - PMC - PubMed
  8.  
    1. Dayal D, Gupta S, Raithatha D, Jayashree M. Missing during COVID‐19 lockdown: children with onset of type 1 diabetes. Acta Paediatr 2020. - PubMed
  9.  
    1. Maahs DM, Hermann JM, Holman N, et al. Rates of diabetic ketoacidosis: international comparison with 49,859 pediatric patients with type 1 diabetes from England, Wales, the U.S., Austria, and Germany. Diabetes Care. 2015;38(10):1876‐1882. - PubMed
  10.  
    1. Wolfsdorf JI, Glaser N, Agus M, et al. ISPAD clinical practice consensus guidelines 2018: diabetic ketoacidosis and the hyperglycemic hyperosmolar state. Pediatr Diabetes. 2018;19(Suppl 27):155‐177. - PubMed
  11.  
    1. Shaltout AA, Wake D, Thanaraj TA, et al. Incidence of type 1 diabetes has doubled in Kuwaiti children 0‐14 years over the last 20 years. Pediatr Diabetes. 2017;18(8):761‐766. - PubMed
  12.  
    1. Al‐Kandari H, Al‐Abdulrazzaq D, Davidsson L, et al. Incidence of type 2 diabetes in Kuwaiti children and adolescents: results from the childhood‐onset diabetes electronic registry (CODeR). Front Endocrinol. 2019;10:836. - PMC - PubMed
  13.  
    1. Group W.H.O.M.G.R.S . WHO child growth standards based on length/height, weight and age. Acta Paediatr Suppl. 2006;450:76‐85. - PubMed
  14.  
    1. Mayer‐Davis EJ, Kahkoska AR, Jefferies C, et al. ISPAD clinical practice consensus guidelines 2018: definition, epidemiology, and classification of diabetes in children and adolescents. Pediatr Diabetes. 2018;19(Suppl 27):7‐19. - PMC - PubMed
  15.  
    1. Usher‐Smith JA, Thompson M, Ercole A, Walter FM. Variation between countries in the frequency of diabetic ketoacidosis at first presentation of type 1 diabetes in children: a systematic review. Diabetologia. 2012;55(11):2878‐2894. - PMC - PubMed
  16.  
    1. Shaltout AA, Channanath AM, Thanaraj TA, et al. Ketoacidosis at first presentation of type 1 diabetes mellitus among children: a study from Kuwait. Sci Rep. 2016;6:27519. - PMC - PubMed
  17.  
    1. Tittel SR, Rosenbauer J, Kamrath C, et al. Did the COVID‐19 lockdown affect the incidence of pediatric type 1 diabetes in Germany? Diabetes Care. 2020;43(11):e172‐e173. - PMC - PubMed
  18.  
    1. Unsworth R, Wallace S, Oliver NS, et al. New‐onset type 1 diabetes in children during COVID‐19: multicenter regional findings in the U.K. Diabetes Care. 2020;43(11):e170‐e171. - PubMed
  19.  
    1. Kamrath C, Mönkemöller K, Biester T, et al. Ketoacidosis in children and adolescents with newly diagnosed type 1 diabetes during the COVID‐19 pandemic in Germany. J Am Med Assoc. 2020;324(8):801‐804. - PMC - PubMed
  20.  
    1. Beliard K, Demeterco‐Berggren C, Alonso GT, Gallagher MP, Clements M, Rapaport R. Increased DKA at presentation among newly diagnosed type 1 diabetes patients with or without COVID‐19: data from a multi‐site surveillance registry. J Diabetes. 2020;13(3):270–272. doi:10.1111/1753-0407 - PubMed
  21.  
    1. Alaqeel A, Aljuraibah F, Alsuhaibani M, et al. The impact of COVID‐19 pandemic lockdown on the incidence of new‐onset type 1 diabetes and ketoacidosis among Saudi children. Front Endocrinol. 2021;12:669302. - PMC - PubMed
  22.  
    1. Lawrence C, Seckold R, Smart C, et al. Increased paediatric presentations of severe diabetic ketoacidosis in an Australian tertiary centre during the COVID‐19 pandemic. Diabet Med. 2021;38(1):e14417. - PMC - PubMed
  23.  
    1. Lazzerini M, Barbi E, Apicella A, Marchetti F, Cardinale F, Trobia G. Delayed access or provision of care in Italy resulting from fear of COVID‐19. Lancet Child Adolesc Health. 2020;4(5):e10‐e11. - PMC - PubMed
  24.  
    1. Shrestha SS, Zhang P, Barker L, Imperatore G. Medical expenditures associated with diabetes acute complications in privately insured U.S. youth. Diabetes Care. 2010;33(12):2617‐2622. - PMC - PubMed

Page Navigation